Genomic alterations of IKZF1 (e.g. deletions) were identified in haematological malignancies, like acute lymphoblastic leukaemia (ALL), with relevance for clinical outcome.3, 4, 5, 6, 7. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.